This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Allgenesis Biotherapeutics Inc.. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: The Innovative Contributions of Riping Phang
Introduction
Riping Phang is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as BACE1 inhibitors. His work aims to address various cognitive disorders and diseases, showcasing his commitment to advancing medical science.
Latest Patents
Riping Phang holds a patent for "Compounds and their use as BACE1 inhibitors." This invention relates to compounds of Formula (I) or their stereoisomers, tautomers, or pharmaceutically acceptable salts or solvates. The patent outlines a pharmaceutical composition that includes these compounds and describes a therapeutic method for treating and preventing conditions such as Down syndrome, Alzheimer's disease, and other neurodegenerative disorders. His innovative approach aims to improve the quality of life for individuals affected by these serious health issues.
Career Highlights
Riping Phang is associated with Allgenesis Biotherapeutics Inc., where he continues to contribute to groundbreaking research and development in the biotherapeutics sector. His work has led to advancements in understanding and treating cognitive impairments and related diseases. With a focus on practical applications of his inventions, he is dedicated to making a positive impact in the medical field.
Collaborations
Riping Phang collaborates with esteemed colleagues, including Yesudoss Christu Rajan and Richard Beresis. These partnerships enhance the research and development process, fostering an environment of innovation and shared expertise.
Conclusion
Riping Phang's contributions to the field of pharmaceuticals through his patent on BACE1 inhibitors highlight his role as an influential inventor. His work not only advances scientific knowledge but also aims to improve the lives of those suffering from cognitive disorders. The impact of his innovations is significant and continues to inspire further research in the field.